Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload

Acta Cardiologica

Volumn 70, Issue 3, 2015, Pages 265-273

  Verbrugge, Frederik H ^a,b   Dupont, Matthias ^a   Bertrand, Philippe B ^a,b   Nijst, Petra ^a,b   Penders, Joris ^a   Dens, Joseph ^a,b   Verhaert, David ^a   Vandervoort, Pieter ^a,b   Tang, W H Wilson ^c   Mullens, Wilfried ^a,b  

^a DEPARTMENT OF CARDIOLOGY   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Acetazolamide; Congestion; Diuretics; Natriuresis

Indexed keywords

ACETAZOLAMIDE; BUMETANIDE; CHLORTALIDONE; FUROSEMIDE; SPIRONOLACTONE; DIURETIC AGENT; LOOP DIURETIC AGENT;

AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DIURETIC ACTIVITY; DIURETIC THERAPY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; HYPERVOLEMIA; HYPOKALEMIA; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; NATRIURESIS; PROSPECTIVE STUDY; TREATMENT OUTCOME; DRUG EFFECTS; HEART STROKE VOLUME; PATHOPHYSIOLOGY;

AGED; BUMETANIDE; COHORT STUDIES; DIURETICS; FEMALE; HEART FAILURE; HUMANS; MALE; NATRIURESIS; PROSPECTIVE STUDIES; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; STROKE VOLUME;

EID: 84930024641     PISSN: 00015385     EISSN: 03737934     Source Type: Journal    
DOI: 10.2143/AC.70.3.3080630     Document Type: Article

References (21)

1. Adams KF, Jr., Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP; ADHERE Scientific Ad visory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005; 149: 209-16.
2. Fonarow GC, Corday E; ADHERE Scientific Advisory Committee. Overview of acutely decompensated congestive heart failure (ADHF): a rep ort from the ADHERE registry. Heart Fail Rev 2004; 9: 179-85.
3. Kramer BK, Schweda F, Riegger GA. Diuretic treatment and diuretic resistance in heart failure. Am J Med 1999; 106: 90-6.
4. Verbrugg e FH, Dupont M, Steels P, Grieten L, Malbrain M, Tang WH, Mullens W. Abdominal contributions to cardiorenal dysfunction in co ngestive heart failure. J Am Coll Cardiol 2013; 62: 485-95.
5. Verbrugge FH, Dupont M, Steels P, Grieten L, Swennen Q, Tang WH, Mullens W. The kidney in congestive heart failure: ‘are natriuresis, sodium, and diuretics really the good, the bad and the ugly?’. Eur J Heart Fail 2014; 16: 133-42.
6. Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS, Schollmeye r MP, Sobotka PA; UNLOAD Trial Investigators. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 675-83.
7. Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP. Potential effects of aggressive decongestion during the treatment of decompen sated heart failure on renal function and survival. Circulation 2010; 122: 265-72.
8. Metra M, Davison B, Bettari L, Sun H, Edwards C, Lazzarini V, Piovanelli B, Carubelli V, Bugatti S, Lombardi C, Cotter G, Dei Cas L. Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail 2012; 5: 54-62.
9. Testani JM, Brisco MA, Turner JM, Spatz ES, Bellumkonda L, Parikh CR, Tang WH. Loop diuretic efficiency: a metric of diuretic respons iveness with prognostic importance in acute decompensated heart failure. Circ Heart failure 2014; 7: 261-70.
10. Singh D, Shrestha K, Testani JM, Verbrugge FH, Dupont M, Mullens W, Tang WH. Insufficient natriuretic response to continuous intrav enous furosemide is associated with poor long-term outcomes in acute decompensated heart failure. J Card Fail 2014; 20: 392-9.
11. Testani JM, Coca SG, McCauley BD, Shannon RP, Kimmel SE. Impact of changes in blood pressure during the treatment of acute decompens ated heart failure on renal and clinical outcomes. Eur J Heart Fail 2011; 13: 877-84.
12. Dupont M, Mullens W, Finucan M, Taylor DO, Starling RC, Tang WH. Determinants of dynamic changes in serum creatinine in acute decomp ensated heart failure: the importance of blood pressure reduction during treatment. Eur J Heart Fail 2013; 15: 433-40.
13. Lewy JE, Windhager EE. Peritubular control of proximal tubular fluid reabsorption in the rat kidney. Am J Physiol 1968; 214: 943-54.
14. Grandchamp A, Boulpaep EL. Pressure control of sodium reabsorption and intercellular backflux across proximal kidney tubule. J Clin Invest 1974; 54: 69-82.
15. Smilde TD, Damman K, van der Harst P, Navis G, Westenbrink BD, Voors AA, Boomsma F, van Veldhuisen DJ, Hillege HL. Differential asso ciations between renal function and “modifiable” risk factors in patients with chronic heart failure. Clin Res Cardiol 2009; 98: 121-9.
16. Knauf H, Mutschler E. Sequential nephron blockade breaks resistance to diuretics in edematous states. J Cardiovasc Pharmacol 1997; 2 9: 367-72.
17. Khan MI. Treatment of refractory congestive heart failure and normokalemic hypochloremic alkalosis with acetazolamide and spironolac tone. Can Med Assoc J 1980; 123: 883-7.
18. Testani JM, Cappola TP, Brensinger CM, Shannon RP, Kimmel SE. Interaction between loop diuretic-associated mortality and blood urea nitrogen concentration in chronic heart failure. J Am Coll Cardiol 2011; 58: 375-82.
19. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortal ity in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341: 709-17.
20. Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B. Eplerenone in patients with systo lic heart failure and mild symptoms. N Engl J Med 2011; 364: 11-21.
21. Tang WH, Vagelos RH, Yee YG, Benedict CR, Willson K, Liss CL, Fowler MB. Neurohormonal and clinical responses to high- versus low-do se enalapril therapy in chronic heart failure. J Am Coll Cardiol 2002; 39: 70-8.